Jen Chia Wu
About Jen Chia Wu
Jen Chia Wu serves as the Director of Assay Development at CellMax Life in Taipei City, Taiwan, where she has worked since 2017. With a background in cancer detection research, she has contributed to various publications and conferences in the field.
Work at CellMax Life
Jen Chia Wu has been serving as the Director of Assay Development at CellMax Life since 2017. In this role, she oversees the development of assays that are critical for cancer detection. Prior to this position, she worked as a Principal Scientist from 2016 to 2017 and as a Senior Scientist from 2014 to 2016, contributing to various projects focused on early cancer detection. Her extensive experience at CellMax Life has allowed her to play a key role in the analytical validation of the CellMax platform.
Education and Expertise
Jen Chia Wu completed her education at the National University Preparatory School for Overseas Chinese Students, where she earned her Doctor of Philosophy degree. Her academic background provides a strong foundation for her expertise in assay development and cancer detection methodologies. This educational experience complements her practical work in the field, particularly in the development and clinical validation of blood tests.
Background
Jen Chia Wu has a robust background in cancer research and assay development. She has worked at CellMax Life for several years in various capacities, including Senior Scientist and Principal Scientist, before becoming the Director of Assay Development. Her work has primarily focused on the detection of circulating tumor cells and the development of blood tests aimed at early detection of colorectal adenomas and cancer.
Research Contributions
Jen Chia Wu has participated in multiple research publications related to cancer detection and blood tests. She has co-authored studies that explore the role of circulating tumor cells in cancer detection. Additionally, her research has been presented at prestigious conferences, including the ASCO Gastrointestinal Cancers Symposium and Digestive Disease Week, highlighting her contributions to the field of oncology.